Related Experiment Videos

Male/female differences in indomethacin effects in preterm infants

Arne Ohlsson1, Robin S Roberts, Barbara Schmidt

  • 1University of Toronto, Toronto, McMaster University, Hamilton, Ontario, Canada.

The Journal of Pediatrics
|December 17, 2005
PubMed

Insights

Indomethacin prophylaxis may have sex-specific effects on severe brain bleeds in extremely-low-birth-weight infants. Further analysis indicates a slight difference in treatment effectiveness between sexes.

Area of Science:

  • Neonatal medicine
  • Pediatric neurology

Background:

  • Severe intraventricular hemorrhage (grade III and IV) is a significant complication in extremely-low-birth-weight infants.
  • Long-term neurodevelopmental outcomes are often affected by such hemorrhages.

Purpose of the Study:

  • To investigate potential sex-mediated effects of indomethacin prophylaxis on severe intraventricular hemorrhage (IVH).
  • To assess if indomethacin's impact on long-term outcomes differs between male and female extremely-low-birth-weight infants.

Main Methods:

  • Secondary analysis of the "Trial of Indomethacin Prophylaxis in Preterms" study cohort.
  • Evaluation of severe IVH (grade III and IV) and long-term outcomes stratified by infant sex.

Main Results:

  • The study suggests a potential for sex-mediated differences in the efficacy of indomethacin prophylaxis.
  • A weak differential treatment effect of indomethacin based on sex was observed.

Conclusions:

  • Indomethacin prophylaxis may not have a uniform effect across both sexes in extremely-low-birth-weight infants.
  • Further research is warranted to elucidate sex-specific responses to indomethacin for preventing IVH and improving outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...